Growing Mistrust in Tech Stocks Turning Into a Market Stampede


What began as a targeted de-grossing across crowded AI positions is rapidly morphing into something far more sinister. Following Friday’s bruising session, which pushed the S&P 500 into official correction territory and wiped out the Nasdaq’s gains for the year, it is becoming increasingly clear that the market is finally pricing in the physical and financial slowdown in data centre buildouts that we have long warned was inevitable.

For months now, we have pointed out that the confluence of high secular supply-chain inflation eating into compute budgets, mounting regulatory and community pushback, rising financing costs, and collapsing token prices would eventually force a reckoning in AI infrastructure spending. Because capital expenditures on AI data centres have accounted for the lion’s share of US economic growth this year, investors are now waking up to the macro contagion risk.

As a result, the selling seems no longer confined to frothy tier-two neoclouds or high-beta chipmakers, and is now spreading to adjacent sectors with direct exposure to the AI funding bottleneck. Major US bank stocks took a heavy beating on Friday, with both Morgan Stanley (MS US) and Goldman Sachs (GS US) sliding sharply alongside fresh reports that ING’s (INGA NA) $500m data centre loan auction underwhelmed and had to be pulled into one-on-one bilateral sales due to weak demand. This corresponds well with our negative stance on Mizuho (8411 JT), one of Japan’s megabanks which we suspect has high exposure to AI funding and investments.

With financing sitting at the very heart of the AI infrastructure bottleneck, credit appetite is clearly souring even as stocks that had been treated as safe havens are engulfed in indiscriminate liquidation as funds scramble to raise cash and cut gross exposure. This seems to suggest that we are witnessing the early stages of true market capitulation, where correlation goes to one and the entire equity complex is being pulled down alongside the deflating AI trade. The only good news for the market could come from the Federal Reserve which, given this market backdrop, will likely be very reluctant to raise rates.

Anthropic IPO Flops as Retail Investors Look to Have Got Fleeced Again

Even Thursday’s record-breaking IPO of Anthropic (ANT US) could not stem the bleeding. Following a 26% increase on the first day above the IPO offer price, the stock gave up much of those gains and then fell 9% the following day, coming perilously close to its $83 initial offer price. Following the poor performance of SpaceX’s (SPCX US) listing back in June, once again retail investors who chased the opening pop look to have been left holding the bag while failing to revive broader risk appetite across semiconductors and hyperscalers.

This underwhelming debut carries serious implications for OpenAI, whose own public listing aspirations for a $1.25trn valuation set in its curtailed $11bn financing round two weeks ago are now completely at the mercy of post-IPO Anthropic’s soggy market reception. If public equity investors refuse to pay nosebleed multiples for a frontier lab whose enterprise revenue is heavily concentrated among a tiny handful of venture-backed startups while facing collapsing token prices and surging physical compute costs, OpenAI’s path to justifying that valuation looks increasingly untenable.

OpenAI Facing a Perilous Road to Financing Posing Existential Risks to SoftBank
Adding to the unease surrounding OpenAI’s ecosystem, Oracle (ORCL US) issued an unusually defensive statement on Friday insisting its multi-gigawatt OpenAI infrastructure contract is now fully funded after this month’s $20bn stock and high-coupon debt raise while pre-emptively dismissing any media reports questioning its vendor financing dependencies as wrong. Given that Oracle recently declared force majeure on its stalled New Mexico data centre project and carries roughly $273bn in off-balance-sheet obligations just as OpenAI weighs resetting its 2027 compute commitments, such assurances look more alarming than reassuring.

Nowhere is the fallout from Anthropic’s underwhelming debut more acute than at SoftBank (9984 JT), which is hugely exposed given its massive $64bn bet on the other frontier model play, OpenAI. For much of this year, we have underlined that SoftBank is the ultimate poster child for all the excesses and froth in the AI space.

Whether it is aggressive debt issuance, mounting capital needs, collateralised accounting, or sheer valuation excess, SoftBank personifies almost every structural flaw we have warned about. Coupled with the ongoing de-rating of Arm (ARM US), which remains the other major pillar of SoftBank’s NAV equation, the squeeze on Masayoshi Son’s balance sheet is tightening fast. We retain SoftBank high among our recommended shorts.

More Questions Raised About Nvidia’s Integrity
Against that deteriorating backdrop, Nvidia (NVDA US) surprised us this week by issuing a notably robust outlook for the current quarter despite major question marks hanging over its sales into South East Asia. Following Monday’s Commerce Department interim final rule requiring export licences for Singapore, Malaysia, Thailand, and Indonesia alongside Brazil and tightening remote-access restrictions, we had suspected management might struggle to maintain visibility. Instead, caretaker CEO Colette Kress argued that persistent supply constraints allow Nvidia to reallocate any delayed orders from non-US regional buyers straight to backlogged customers elsewhere, keeping near-term revenue targets intact.

Yet the market quickly looked past the upbeat forecasts, given that the new CEO was pointing to a more disciplined approach to circular financing, which raises serious questions about the future funding of neoclouds as well as OpenAI. Adding to the pressure, reports surfaced late in the week confirming that the SEC has opened an investigation into Nvidia’s accounting practices, triggering a brutal 13% single-day sell-off on Friday.

With regulators scrutinising circular AI financing arrangements, revenue quality, and geographic billing disclosures right as Singapore-billed revenues sit under the microscope, the probe adds fresh accounting uncertainty to a balance sheet already weighed down by over $530bn in off-balance-sheet commitments and neocloud guarantees. We await the outcome of the SEC report with interest while keeping a very cautious stance regarding this AI chip pioneer ahead of Jensen Huang’s testimony to US Congress committees scheduled on 1 December.